Loading...

Brett Ley, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Los AngelesB.S.2004Molecular, Cell, Developmental Biology
    University of California, San FranciscoM.D.2008 Medicine
    University of California, San FranciscoResidency, Internal Medicine2011Medicine
    University of California, San FranciscoChief Resident, Internal Medicine2012Medicine
    University of California, San FranciscoFellowship, Pulmonary and Critical Care2015Medicine
    University of California, San FranciscoM.A.S. in Clinical Research2016Epidemiology and Biostatistics

    Collapse Research 
    Collapse Research Activities and Funding
    Integrating clinical and molecular markers for risk prediction in idiopathic pulm
    NIH/NHLBI F32HL124895Aug 1, 2014 - Jul 31, 2017
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Telomere length in patients with unclassifiable interstitial lung disease: a cohort study. Eur Respir J. 2020 Aug; 56(2). Ley B, Liu S, Elicker BM, Henry TS, Vittinghoff E, Golden JA, Jones KD, Wolters PJ. PMID: 32341108.
      View in: PubMed   Mentions:    Fields:    
    2. Impact of idiopathic pulmonary fibrosis on longitudinal healthcare utilization in a community-based cohort of patients. Chest. 2020 Jul 24. Farrand E, Iribarren C, Vittinghoff E, Levine-Hall T, Ley B, Minowada G, Collard HR. PMID: 32717266.
      View in: PubMed   Mentions:    Fields:    
    3. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF. Respirology. 2020 Jun; 25(6):629-635. Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR. PMID: 31846126.
      View in: PubMed   Mentions: 1     Fields:    
    4. COUNTERPOINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? No. Chest. 2019 08; 156(2):205-208. Ley B. PMID: 31395256.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Rebuttal From Dr Ley. Chest. 2019 08; 156(2):209-210. Ley B. PMID: 31395258.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723. Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley B. PMID: 31181198.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia. Histopathology. 2019 Jun; 74(7):1088-1097. Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, Brownell R, Liu S, Collard HR, Jones KD. PMID: 30742318.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. 3541 The association of corticosteroid use with inpatient mortality in acute exacerbation of idiopathic pulmonary fibrosis. Journal of Clinical and Translational Science. 2019 Mar 1; 3(Suppl 1):127-128. Erica Farrand, Eric Vittinghoff, Brett Ley, Harold Collard. .
      View in: Publisher Site   Mentions:
    9. Analysis of pulmonary features and treatment approaches in the COPA syndrome. ERJ Open Res. 2018 Apr; 4(2). Tsui JL, Estrada OA, Deng Z, Wang KM, Law CS, Elicker BM, Jones KD, Dell SD, Gudmundsson G, Hansdottir S, Helfgott SM, Volpi S, Gattorno M, Waterfield MR, Chan AY, Chung SA, Ley B, Shum AK. PMID: 29977900.
      View in: PubMed   Mentions:
    10. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 09 15; 196(6):756-761. Ley B, Swigris J, Day BM, Stauffer JL, Raimundo K, Chou W, Collard HR. PMID: 28471697.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    11. Clarity on Endpoints for Clinical Trials in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2017 09; 14(9):1383-1384. Ley B. PMID: 28862501.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med. 2017 08; 5(8):639-647. Ley B, Newton CA, Arnould I, Elicker BM, Henry TS, Vittinghoff E, Golden JA, Jones KD, Batra K, Torrealba J, Garcia CK, Wolters PJ. PMID: 28648751.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    13. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017 11; 152(5):999-1007. Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS. PMID: 28629914.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 06; 127:51-56. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. PMID: 28502419.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    15. A Glimpse into the Future: Automated Quantitative Computed Tomography as a Biomarker in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017 04 01; 195(7):850-852. Ley B. PMID: 28362206.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Reduction in Non-Elective Respiratory-Related Hospitalizations in Patients Treated With Pirfenidone: Pooled Analyses from Three Phase 3 Trials of Pirfenidone in Idiopathic Pulmonary Fibrosis. Pneumologie. 2017 Feb 23; 71(S 01):s1-s125. U Costabel, JJ Swigris, B Ley, J Stauffer, W Chou, K Raimundo, H Collard. .
      View in: Publisher Site   Mentions:
    17. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017 May; 72(5):424-429. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B. PMID: 28082530.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    18. P173 Reduction in non-elective respiratory-related hospitalizations in patients treated with pirfenidone: pooled analyses from three phase 3 trials of pirfenidone in idiopathic pulmonary fibrosis. Thorax. 2016 Dec 1; 71(Suppl 3):a177. B Ley, JJ Swigris, B Day, J Stauffer, W Chou, K Raimundo, H Collard. .
      View in: Publisher Site   Mentions:
    19. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. Chest. 2017 03; 151(3):619-625. Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B. PMID: 27816444.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    20. Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 09 15; 194(6):711-8. Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR. PMID: 26938706.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    21. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax. 2016 10; 71(10):951-4. Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR. PMID: 27245779.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1147-8. Ley B, Collard HR. PMID: 26568236.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Models of disease behavior in idiopathic pulmonary fibrosis. BMC Med. 2015 Sep 24; 13:165. Johannson KA, Ley B, Collard HR. PMID: 26400574.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Aug; 109(8):1058-62. Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR. PMID: 26140806.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis. Eur Respir J. 2015 May; 45(5):1374-81. Ley B, Bradford WZ, Weycker D, Vittinghoff E, du Bois RM, Collard HR. PMID: 25614172.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    26. Molecular biomarkers in idiopathic pulmonary fibrosis. . 2014 Nov 01; 307(9):L681-91. Ley B, Brown KK, Collard HR. PMID: 25260757.
      View in: PubMed   Mentions:
    27. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology. 2014 Nov; 273(2):570-9. Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR. PMID: 24927326.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    28. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014 Apr; 145(4):723-728. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR. PMID: 24114524.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    29. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013 Nov 25; 5:483-92. Ley B, Collard HR. PMID: 24348069.
      View in: PubMed   Mentions:
    30. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013 Jul; 144(1):234-240. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR. PMID: 23370641.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    31. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012 May 15; 156(10):684-91. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE, Collard HR. PMID: 22586007.
      View in: PubMed   Mentions: 171     Fields:    Translation:Humans
    32. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax. 2012 May; 67(5):407-11. Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE, Ryu JH, Collard HR. PMID: 22426899.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    33. Risk prediction in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012 Jan 01; 185(1):6-7. Ley B, Collard HR. PMID: 22210784.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology. 2011 Aug; 16(6):969-75. Ryerson CJ, Abbritti M, Ley B, Elicker BM, Jones KD, Collard HR. PMID: 21615619.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    35. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Feb 15; 183(4):431-40. Ley B, Collard HR, King TE. PMID: 20935110.
      View in: PubMed   Mentions: 314     Fields:    Translation:Humans
    Brett's Networks
    Concepts (113)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _